Live Breaking News & Updates on Colin Kellaher

Stay updated with breaking news from Colin kellaher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma

By Colin Kellaher


Bristol Myers Squibb has won U.S. Food and Drug Administration expanded approval of its CAR-T cell therapy Breyanzi for adults with relapsed or refractory follicular lymphoma. ....

Colin Kellaher , Bristol Myers Squibb , Drug Administration , Myers Squibb , Dow Jones ,

Eli Lilly Says Once-Weekly Insulin Meets Key Goal in Two Studies

By Colin Kellaher


Eli Lilly on Thursday said a pair of late-stage studies of its proposed once-weekly insulin efsitora alfa met their primary endpoints.

The Indianapolis drugmaker said. ....

Colin Kellaher , Eli Lilly , Dow Jones ,

Johnson & Johnson Strikes $850 Million Deal to Boost Dermatology Portfolio

By Colin Kellaher


Johnson & Johnson has agreed to buy privately-held biotechnology company Proteologix for an initial $850 million in cash in a deal that bolsters the healthcare giant s. ....

Colin Kellaher , New Brunswick , Dow Jones ,

Eli Lilly Ethics/Compliance Chief Alonzo Weems to Retire

Eli Lilly Ethics/Compliance Chief Alonzo Weems to Retire
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Colin Kellaher , Eli Lilly , Alonzo Weems , Dow Jones ,